About: Phase II evaluation of adriamycin in human neoplasia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phase II evaluation of adriamycin in human neoplasia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1973

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1973 (uk) artículu científicu espublizáu en xunetu de 1973 (ast) scientific article published on 01 July 1973 (en) im Juli 1973 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q69548231-294CD7D3-6FB7-4579-BA20-7D19F40F7E50
publication date	1973-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q69548231-57AA870C-F44A-4E55-BD7B-638485422EFB
language of work or name	English
author name string	wds:Q69548231-05E071E0-2C1B-4D46-BD00-1E1105B74557 wds:Q69548231-12A58115-A8FB-45CD-83AC-7F26786F7D88 wds:Q69548231-8F313F92-65BF-4D1B-97B0-F56D04981E5A wds:Q69548231-902B9B78-F643-49C3-AC83-72A9759EC4DF wds:Q69548231-9C5E6C3F-B0FE-4DB5-B434-B56345A2FDBF wds:Q69548231-9E49DAAA-FEAD-409B-8969-8C9E0982F0A3
author name string	G Bonadonna L H Baker J K Luce R W Talley J A Gottlieb R M O'Bryan
rdfs:label	Phase II evaluation of adriamycin in human neoplasia (en) Phase II evaluation of adriamycin in human neoplasia (nl)
skos:prefLabel	Phase II evaluation of adriamycin in human neoplasia (en) Phase II evaluation of adriamycin in human neoplasia (nl)
name	Phase II evaluation of adriamycin in human neoplasia (en) Phase II evaluation of adriamycin in human neoplasia (nl)
title	wds:Q69548231-1356FA31-C3DB-4922-9671-68655FC2FA63
title	Phase II evaluation of adriamycin in human neoplasia (en)
page(s)	wds:Q69548231-7198A0BB-C788-45B7-9242-8609EA79AEC1
page(s)	1-8
instance of	wds:Q69548231-A60EC750-4182-4120-A800-F613968FE69A
instance of	scholarly article
main subject	wds:Q69548231-9CC1AB34-B569-475A-97E1-3F5385325537
main subject	wd:Q18936
PubMed ID	wds:Q69548231-6BCA1C15-21F3-4A82-96B6-FC2530DFF6F2
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4716773
PubMed ID	4716773
published in	wds:Q69548231-F883219C-E68E-41DD-8071-BDC522C55CEA
published in	Cancer
issue	wds:Q69548231-C4101F8F-0708-4AE3-8B98-6FD73D42E073
volume	wds:Q69548231-FCAAC18B-AC4F-434D-B350-7879C4914952
issue	1
volume	32
DOI	wds:Q69548231-42176351-2951-4AFC-B66E-1EFE8CEBD958
DOI	http://dx.doi.org/10.1002/1097-0142(197307)32:1%3C1::AID-CNCR2820320101%3E3.0.CO;2-X
DOI	10.1002/1097-0142(197307)32:1<1::AID-CNCR2820320101>3.0.CO;2-X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69548231
is cites work of	Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells Treatment of hepatocellular carcinoma with adriamycin.Preliminary communication The cost implications of the use of pegylated liposomal doxorubicin when choosing an anthracycline for the treatment of platinum-resistant ovarian cancer: A low-value intervention? The Current and Future Therapies for Human Osteosarcoma Cancer chemotherapy and cardiac arrhythmias: a review. Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcoma Chemotherapy of malignant hemangiopericytoma Doxorubicin cardiotoxicity Sudden death during doxorubicin administration Single and combination chemotherapy for primary murine bladder cancer The treatment of soft tissue sarcomas with focus on chemotherapy: a review Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas Phase II Trial Of Pegylated-liposomal Doxorubicin (Doxil™) In Sarcoma* Adriamycin in the treatment of childhood solid tumors.A southwest oncology group study Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention Radiation-adriamycin interactions: Preliminary clinical observations 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data Adriamycin (doxorubicin) cardiotoxicity: a review The chemotherapy of urologic cancer Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults Multidisciplinary treatment of embryonal rhabdomyosarcoma in children Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor Treatment of bronchogenic carcinoma. II. Small cell Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma Role of Antitumor Antibiotics in Current Oncologic Practice Increased incidence of cerebral metastases in sarcoma patients with prolonged survival from chemotherapy.Report of cases of leiomysarcoma and chondrosarcoma Systemic chemotherapy of transitional cell carcinoma of the urothelium Phase II Trial of Doxorubicin in Bidimensionally Measurable Prostatic Adenocarcinoma Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivity Distribution of doxorubicin to normal breast and tumour tissue in patients undergoing mastectomy Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Swiss Group for Clinical Research (SAKK) Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles Adriamycin and 1-(2-Chlorethyl)-3-Cyclohexyl-1-Nitrosourea (CCNU) in the treatment of metastatic breast cancer Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans Electrocardiographic changes after adriamycin chemotherapy A paucity of chronic electrocardiographic changes with adriamycin therapy Chemotherapy of advanced transitional-cell carcinoma of the bladder Adriamycin in advanced urinary tract cancer.Experience in 42 patients and review of the literature Cyvadic in advanced soft tissue sarcoma: A randomized study comparing two schedules: A study of the EORTC soft tissue and bone sarcoma group Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer The management of inadvertent subcutaneous adriamycin infiltration

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software